This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Elaine Pirie, PhD
Assistant Director, Antisense Drug Discovery at Ionis Pharmaceuticals


Elaine is an Assistant Director at Ionis Pharmaceuticals, where her research is focused on the uptake of antisense oligonucleotides (ASOs) into the beta cell for the treatment of diabetes. She received her undergraduate degree from the University of Wisconsin-Madison and her PhD from the University of California San Diego. Elaine then joined Ionis Pharmaceuticals as a postdoctoral fellow, using genetic models to understand ASO uptake and trafficking in the liver. She later began working on using GLP-1 conjugated ASOs to deliver ASO to the beta cell of the pancreas. Her research areas focus on evaluating and improving GLP-1 conjugated ASO uptake and identifying novel targets for diabetes.

Agenda Sessions

  • GLP-1 Mediated Uptake of Antisense Oligonucleotide into Beta Cells of the Pancreas